Хайлтын үр дүнгүүд - Enjeti, Anoop
- 20-н 1 - 20 үр дүнгүүдийг харуулж байна
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Outcomes and relapse patterns following chemotherapy in advanced Hodgkin lymphoma in the positron emission tomography era -н Lapuz, Carminia, Enjeti, Anoop K, O’Brien, Peter C, Capp, Anne L, Holliday, Elizabeth G, Gupta, Sanjiv A
Хэвлэсэн 2018текст -
8
Strategies for enumeration of circulating microvesicles on a conventional flow cytometer: Counting beads and scatter parameters -н Alkhatatbeh, Mohammad J, Enjeti, Anoop K, Baqar, Sara, Ekinci, Elif I, Liu, Dorothy, Thorne, Rick F, Lincz, Lisa F
Хэвлэсэн 2018текст -
9
-
10
Consensus guidelines for the management of adult immune thrombocytopenia in Australia and New Zealand -н Choi, Philip YI, Merriman, Eileen, Bennett, Ashwini, Enjeti, Anoop K, Tan, Chee Wee, Goncalves, Isaac, Hsu, Danny, Bird, Robert
Хэвлэсэн 2021текст -
11
Intensive care unit outcomes in patients with hematological malignancy -н Rawson, Jarrod Leigh, Fagan, Fionnuala Mary, Burrough, Georgin Claire, Tang, Helen Michelle, Cuncannon, Moire Alys, Ellem, Katrina Louise, Enjeti, Anoop Kumar
Хэвлэсэн 2020текст -
12
scTEM-seq: Single-cell analysis of transposable element methylation to link global epigenetic heterogeneity with transcriptional programs -н Hunt, Kooper V., Burnard, Sean M., Roper, Ellise A., Bond, Danielle R., Dun, Matthew D., Verrills, Nicole M., Enjeti, Anoop K., Lee, Heather J.
Хэвлэсэн 2022текст -
13
Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework -н Lau, Colleen L., Mayfield, Helen J., Sinclair, Jane E., Brown, Samuel J., Waller, Michael, Enjeti, Anoop K., Baird, Andrew, Short, Kirsty R., Mengersen, Kerrie, Litt, John
Хэвлэсэн 2021текст -
14
Immune thrombocytopenia following vaccination during the COVID-19 pandemic -н Choi, Philip Young-Ill, Hsu, Danny, Tran, Huyen Anh, Tan, Chee Wee, Enjeti, Anoop, Chen, Vivien Mun Yee, Chong, Beng Hock, Curnow, Jennifer, Pepperell, Dominic, Bird, Robert
Хэвлэсэн 2021текст -
15
Healthcare resource utilization trends in patients with acute myeloid leukemia ineligible for intensive chemotherapy receiving first‐line systemic treatment or best supportive care... -н Ito, Tomoki, Sanford, David, Tomuleasa, Ciprian, Hsiao, Hui‐Hua, Olivera, Leonardo José Enciso, Enjeti, Anoop Kumar, Conca, Alberto Gimenez, del Castillo, Teresa Bernal, Girshova, Larisa, Martelli, Maria Paola, Guvenc, Birol, Bui, Cat N., Delgado, Alex, Duan, Yinghui, Guijarro, Belen Garbayo, Llamas, Cynthia, Lee, Je‐Hwan
Хэвлэсэн 2022текст -
16
Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitors -н Smith, Amanda M., Dun, Matthew D., Lee, Erwin M., Harrison, Celeste, Kahl, Richard, Flanagan, Hayley, Panicker, Nikita, Mashkani, Baratali, Don, Anthony S., Morris, Jonathan, Toop, Hamish, Lock, Richard B., Powell, Jason A., Thomas, Daniel, Guthridge, Mark A., Moore, Andrew, Ashman, Leonie K., Skelding, Kathryn A., Enjeti, Anoop, Verrills, Nicole M.
Хэвлэсэн 2016текст -
17
Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study -н Wei, Andrew H., Strickland, Stephen A., Hou, Jing-Zhou, Fiedler, Walter, Lin, Tara L., Walter, Roland B., Enjeti, Anoop, Tiong, Ing Soo, Savona, Michael, Lee, Sangmin, Chyla, Brenda, Popovic, Relja, Salem, Ahmed Hamed, Agarwal, Suresh, Xu, Tu, Fakouhi, Kaffa M., Humerickhouse, Rod, Hong, Wan-Jen, Hayslip, John, Roboz, Gail J.
Хэвлэсэн 2019текст -
18
Quantitative phosphoproteomics uncovers synergy between DNA-PK and FLT3 inhibitors in acute myeloid leukaemia -н Murray, Heather C., Enjeti, Anoop K., Kahl, Richard G. S., Flanagan, Hayley M., Sillar, Jonathan, Skerrett-Byrne, David A., Al Mazi, Juhura G., Au, Gough G., de Bock, Charles E., Evans, Kathryn, Smith, Nathan D., Anderson, Amanda, Nixon, Brett, Lock, Richard B., Larsen, Martin R., Verrills, Nicole M., Dun, Matthew D.
Хэвлэсэн 2020текст -
19
Shwachman–Bodian–Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia -н Dun, Matthew D., Mannan, Abdul, Rigby, Callum J., Butler, Stephen, Toop, Hamish D., Beck, Dominik, Connerty, Patrick, Sillar, Jonathan, Kahl, Richard G. S., Duchatel, Ryan J., Germon, Zacary, Faulkner, Sam, Chi, Mengna, Skerrett-Byrne, David, Murray, Heather C., Flanagan, Hayley, Almazi, Juhura G., Hondermarck, Hubert, Nixon, Brett, De Iuliis, Geoff, Chamberlain, Janis, Alvaro, Frank, de Bock, Charles E., Morris, Jonathan C., Enjeti, Anoop K., Verrills, Nicole M.
Хэвлэсэн 2020текст -
20
COVID‐19 vaccination in haematology patients: an Australian and New Zealand consensus position statement -н McCaughan, Georgia, Di Ciaccio, Pietro, Ananda‐Rajah, Michelle, Gilroy, Nicole, MacIntyre, Raina, Teh, Benjamin, Weinkove, Robert, Curnow, Jennifer, Szer, Jeff, Enjeti, Anoop K, Ross, David M, Mulligan, Stephen, Trotman, Judith, Dickinson, Michael, Quach, Hang, Choi, Phillip, Polizzotto, Mark N., Tam, Constantine S., Ho, P. Joy, Ku, Matthew, Gregory, Gareth, Gangatharan, Shane, Hapgood, Greg, Cochrane, Tara, Cheah, Chan, Gibbs, Simon, Wei, Andrew, Johnston, Anna, Greenwood, Matthew, Prince, H. Miles, Latimer, Maya, Berkahn, Leanne, Wight, Joel, Armytage, Tasman, Hamad, Nada
Хэвлэсэн 2021текст